Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT06917469
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of a first relapse of high-grade ovarian cancer (≥12 months after the last platinum administration);
* p53 positive tumors evaluated by IHC (\>30% of stained tumor cells);
* Performance Status (Eastern Cooperative Oncology Group scale, ECOG) ≤ 2;- Availability of the tumor sample for immunohistochemical analysis;
* Written informed consent.
Exclusion Criteria:
* Pre-existing or concurrent tumors, except in situ carcinoma or basophilic carcinoma of the skin;
* Low p53 expression levels (\<30% of stained tumor cells);
* Persistent grade≥ 2 neuropathy;
* Severe heart disease;
* Surgeon's decision of a second curative surgery;
* Uncontrolled active infections;
* Insufficient patient compliance;
* Absence of signed informed consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06917469
Study Brief:
Protocol Section:
NCT06917469